Leading environment management company, Ion Exchange commissioned the country's first ANDICOS waste to energy production system in Hyderabad, Telengana.

Buzzing with IPOs, so far FY18 has witnessed the listing of 43 companies to raise an aggregate sum of Rs. 805 billion. The funds raised from initial public offerings have recorded a tremendous increase over the years, as compared to Rs. 413 billion raised by 84 companies in FY08.

Taking a decisive step in its attempt to privatise the debt-ridden national carrier, Air India, the government on Wednesday invited expressions of interest from bidder seeking to acquire controlling stake in the entity.

Infrastructure major MEP Infrastructure Developers announced on Wednesday that it has bagged orders worth Rs. 2,922.83 crore in Maharashtra through a joint venture with Long Jian Road & Bridge Company.

Oriental Bank which is one of the lead lender with half of the loan exposure has filed a complaint against Lotus Auto Engineering with NCLT (National Company Law Tribunal),

During FY18, the benchmark index Sensex has gone through various jolts, but despite this, the Sensex has delivered a 14.3 per cent growth in the fiscal year 2018.

If the public sector banks are facing scrutiny for loans sanctioned on back of pressures from the government or influential politicians, the private banks are now under the scanner for vested interests and other such possible favoritism in granting of unworthy loans to defaulting borrowers.

With the current market volatility, it is very significant for a mutual fund investor to pick right mutual fund schemes from the range of schemes available in the market. To tackle with the market volatility, it is important to look into the risks involved in the investment of particular scheme

Adding to the string of banking system frauds disclosed in the recent times, IDBI Bank announced on Tuesday that it has uncovered fraudulent loans worth Rs. 7.72 billion that were issued from five of its branches in Andhra Pradesh and Telangana.

Pharma major Alkem Laboratories nosedived by 11 per cent on Wednesday as the US Food and Drug Administration issued 13 observations to the company’s Daman facility and one observation to its US based manufacturing unit.